Groundbreaking Study Highlights Increased Risks Linked to COVID-19 Vaccines

In an expansive and comprehensive study conducted by the Global Vaccine Data Network (GVDN), scientists examined health outcomes of 99 million individuals who received COVID-19 vaccines. The findings have caused a significant stir, as they point to increased risks of developing several severe health conditions after vaccination, challenging prior conceptions of vaccine safety. The GVDN study focused on assessing the potentially heightened risks of several health concerns following immunization with three of the main COVID-19 vaccines: Moderna, AstraZeneca, and Pfizer. The risks were evaluated by comparing the health data of vaccinated individuals against pre-pandemic health records, essentially examining what the state of health would have been if these individuals had not been vaccinated. The stark figures presented in the study include a nearly fourfold increase in the risk of developing encephalomyelitis, swelling of the brain and spinal cord, following the first dose of the Moderna vaccine. Additionally, there was a 3.48 times greater risk of myocarditis and a 1.74 times greater chance of pericarditis. Subsequent doses showed even more significant risks, with a 6.1 times increased risk of myocarditis for the second Moderna shot, and a second round of AstraZeneca elevating the risk of pericarditis by a staggering 6.91 times. When it comes to Pfizer, the third dose of the vaccine was associated with a 2.09 times increase in myocarditis risk, whereas the first and second doses had slightly higher risks of 2.78 and 2.86 times, respectively. Furthermore, Moderna's later doses—beyond the initial shot—revealed a 2.64 times increased risk of pericarditis for the fourth dose and a 2.01 times heightened risk of myocarditis from the third dose. These isolated risk factors, troubling as they are when considered individually, lead to a compounded concern when multiple doses are taken into account. The cumulative effect could, theoretically, multiply these risks substantially, leading to a much more significant likelihood of developing these health issues. The implications of GVDN's research are considerable and have prompted a necessary debate over the roll-out and safety of these vaccines. The issue is not just a question of individual health concerns but also broader questions of public health policy and vaccine trust. Notably, these findings do not negate the benefits that vaccination has played in controlling the COVID-19 pandemic; however, they do suggest that a more nuanced approach may be necessary as we move forward. Experts are urging caution in interpreting these results, emphasizing that while the increased risks are significant, the overall incidence of these conditions remains relatively low. Health authorities and the scientific community are also quick to point out that the benefits of COVID-19 vaccination in preventing severe illness, hospitalization, and death still heavily outweigh these risks for the majority of the population. Nevertheless, the GVDN study cannot be overlooked. It presents factual, evidence-based findings that warrant closer scrutiny of current vaccination practices and protocols. It also highlights the importance of continued vaccine research and the need for transparent communication between health authorities and the public regarding potential vaccine-related risks. In the wake of this study, further research is needed to determine long-term health outcomes and to create more comprehensive risk profiles for individuals considering vaccination. The emphasis is also on ensuring that informed consent is genuinely informed, providing the public with an accurate understanding of both the advantages and potential downsides of COVID-19 vaccines.

Largest Vaccine Study Ever Reveals What the "Conspiracy Theorists" Said All Along

Scientists found MASSIVE increased risks of developing several serious health conditions post-jab.

But headlines suggest they're "small" and "rare." Take a look for yourself.

Moderna (1st Dose):… pic.twitter.com/XEI6pcKHAt

— The Vigilant Fox 🦊 (@VigilantFox) February 23, 2024